Additionally, higher blood levels of NfL and GFAP [7, 17] and longitudinal increases blood levels of NfL [16, 20, 21] and pTau-181 [18] have been associated with decreased volume in AD-vulnerable brain regions. This evidence concerns the gene NEFL and Alzheimer disease.